Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer. [electronic resource]
Producer: 20140818Description: 9157-62 p. digitalISSN:- 1091-6490
- Autoantigens -- biosynthesis
- Breast Neoplasms -- drug therapy
- Cell Line, Tumor
- DNA-Binding Proteins
- Drug Delivery Systems
- Enzyme Inhibitors -- pharmacology
- Gene Expression Regulation, Enzymologic -- drug effects
- Gene Expression Regulation, Neoplastic -- drug effects
- Gene Knockdown Techniques
- Histone Chaperones -- biosynthesis
- Humans
- Intracellular Signaling Peptides and Proteins
- Membrane Proteins -- biosynthesis
- Protein Phosphatase 2 -- antagonists & inhibitors
- Proto-Oncogene Proteins c-myc -- genetics
- Transcription Factors -- biosynthesis
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.